Business Description
Liquidia Corp
NAICS : 325414
SIC : 2836
ISIN : US53635D2027
Share Class Description:
STU:LT4: Ordinary SharesDescription
Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also generates revenue from the sale of Treprostinil Injection through an agreement between its subsidiary and the manufacturer.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 75.95 | |||||
| Equity-to-Asset | 0.44 | |||||
| Debt-to-Equity | 0.02 | |||||
| Debt-to-EBITDA | -0.03 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 0.75 | |||||
| Beneish M-Score | -2.93 | |||||
| WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 130.4 | |||||
| 3-Year EBITDA Growth Rate | 13.2 | |||||
| 3-Year EPS without NRI Growth Rate | 12.6 | |||||
| 3-Year FCF Growth Rate | 20.5 | |||||
| 3-Year Book Growth Rate | -25.1 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 41.85 | |||||
| Future 3-5Y Total Revenue Growth Rate | 128.16 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 87.39 | |||||
| 9-Day RSI | 75.5 | |||||
| 14-Day RSI | 68.39 | |||||
| 6-1 Month Momentum % | -11.94 | |||||
| 12-1 Month Momentum % | 62.64 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 6.33 | |||||
| Quick Ratio | 6.33 | |||||
| Cash Ratio | 6.04 | |||||
| Days Inventory | 237.4 | |||||
| Days Sales Outstanding | 81.46 | |||||
| Days Payable | 181.73 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -16.6 | |||||
| Shareholder Yield % | -13.52 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 64.65 | |||||
| Operating Margin % | -715.07 | |||||
| Net Margin % | -765.38 | |||||
| FCF Margin % | -592.6 | |||||
| ROE % | -168.37 | |||||
| ROA % | -69.68 | |||||
| ROIC % | -290.17 | |||||
| ROC (Joel Greenblatt) % | -1495.42 | |||||
| ROCE % | -73.26 |
GF Value Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 54.53 | |||||
| PB Ratio | 8.89 | |||||
| Price-to-Tangible-Book | 9.54 | |||||
| EV-to-EBIT | -7.14 | |||||
| EV-to-EBITDA | -7.29 | |||||
| EV-to-Revenue | 50.06 | |||||
| EV-to-Forward-Revenue | 34.77 | |||||
| EV-to-FCF | -8.45 | |||||
| Price-to-Net-Current-Asset-Value | 13.6 | |||||
| Price-to-Net-Cash | 16 | |||||
| Earnings Yield (Greenblatt) % | -14.01 | |||||
| FCF Yield % | -9.41 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Liquidia Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 14.296 | ||
| EPS (TTM) (€) | -1.496 | ||
| Beta | 0.46 | ||
| Volatility % | 75.48 | ||
| 14-Day RSI | 68.39 | ||
| 14-Day ATR (€) | 0.251866 | ||
| 20-Day SMA (€) | 9.848 | ||
| 12-1 Month Momentum % | 62.64 | ||
| 52-Week Range (€) | 6.35 - 15.56 | ||
| Shares Outstanding (Mil) | 84.64 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Liquidia Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Liquidia Corp Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Liquidia Corp Frequently Asked Questions
What is Liquidia Corp(STU:LT4)'s stock price today?
The current price of STU:LT4 is €10.88. The 52 week high of STU:LT4 is €15.56 and 52 week low is €6.35.
When is next earnings date of Liquidia Corp(STU:LT4)?
The next earnings date of Liquidia Corp(STU:LT4) is 2025-03-13 Est..
Does Liquidia Corp(STU:LT4) pay dividends? If so, how much?
Liquidia Corp(STU:LT4) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers